Nvidia, Evozyne create generative AI model for proteins - IT-Online

Using a pretrained AI model from Nvidia, startup Evozyne has created two proteins with significant potential in healthcare and clean energy. A joint paper released today describes the process and the biological building blocks it produced. One aims to cure a congenital disease, another is designed to consume carbon dioxide to reduce global warming. Initial results show a new way to accelerate drug discovery and more. "It's been really encouraging that even in this first round the AI model has produced synthetic proteins as good as naturally occurring ones," says Andrew Ferguson, Evozyne's co-founder and a co-author of the paper.